Hjem › In situ-carcinom
In situ-carcinom kliniske forsøg rekrutterer i USA
8 studier for In situ-carcinom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Austin, TX4 studier
- Little Rock, AR4 studier
- Houston, TX4 studier
- Boston, MA4 studier
- New York City, NY3 studier
- Cincinnati, OH3 studier
- Bakersfield, CA3 studier
- Portland, OR3 studier
- Philadelphia, PA3 studier
- Memphis, TN3 studier
- Los Angeles, CA3 studier
- Rochester, MN3 studier
- Pittsburgh, PA3 studier
- Nashville, TN3 studier
- Birmingham, AL3 studier
- Syracuse, NY3 studier
- Jacksonville, FL3 studier
- Myrtle Beach, SC3 studier
- St. Louis, MO3 studier
- Atlanta, GA3 studier
Efter delstat
- Alabama3 studier
- Arizona4 studier
- Arkansas4 studier
- Californien5 studier
- Colorado4 studier
- Florida4 studier
- Georgia3 studier
- Illinois3 studier
- Louisiana3 studier
- Massachusetts4 studier
- Minnesota3 studier
- Missouri4 studier
- New York4 studier
- Ohio4 studier
- Oregon3 studier
- Pennsylvania5 studier
- South Carolina4 studier
- Tennessee4 studier
- Texas5 studier
- Virginia4 studier
- Washington3 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06833073Project: Every Child for Younger Patients With Cancer
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 21. aug. 2026 · NCT07480356InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT05463796LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT04752722Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
RekruttererFase 2
Alder 18 til 99 · Alle køn · Opdateret 17. apr. 2026 · NCT07322263EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Rekrutterer
Alder 20 til 89 · Kvinder · Opdateret 4. feb. 2026 · NCT06115486Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.